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Abstract
Goal—A recent experiment demonstrated that when humans wear unpowered elastic ankle 
exoskeletons with intermediate spring stiffness they can reduce their metabolic energy cost to walk 
by ~7%. Springs that are too compliant or too stiff have little benefit. The purpose of this study 
was to use modeling and simulation to explore the muscle-level mechanisms for the ‘sweet-spot’ 
in stiffness during exoskeleton assisted walking.
Methods—We developed a simple lumped, uniarticular musculoskeletal model of the 
plantarflexors operating in parallel with an elastic ‘exo-tendon’. Using an inverse approach with 
constrained kinematics and kinetics, we rapidly simulated human walking over a range of 
exoskeleton stiffness values and examined the underlying neuromechanics and energetics of the 
biological plantarflexors.
Results—Stiffer ankle exoskeleton springs resulted in larger decreases in plantarflexor muscle 
forces, activations and metabolic energy consumption. However, in the process of unloading the 
compliant biological muscle-tendon unit (MTU), the muscle fascicles (CE) experienced larger 
excursions that negatively impacted series elastic element (SEE) recoil that is characteristic of a 
tuned ‘catapult mechanism’.
Conclusion—The combination of disrupted muscle-tendon dynamics and the need to produce 
compensatory forces/moments to maintain overall net ankle moment invariance could explain the 
‘sweet spot’ in metabolic performance at intermediate ankle exoskeleton stiffness. Future work 
will aim to provide experimental evidence to support the model predictions presented here using 
ultrasound imaging of muscle-level dynamics during walking with elastic ankle exoskeletons.
Significance—Engineers must account for the muscle-level effects of exoskeleton designs in 
order to achieve maximal performance objectives.
Index Terms
ankle exoskeleton; computer simulation; elastic energy storage; energetics; Hill-type muscle 
model; metabolic cost; muscle-tendon dynamics; plantarflexors; human walking
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I. Introduction
Human walking [4], hopping [5], and running [6] all exhibit compliant dynamics that can be 
captured by simple spring-mass models. In essence, the lower-limb is able to compress and 
recoil elastically with stiffness that arises from the combination of passive, non-linear 
material properties of the muscles and series elastic connective tissues, and active 
neuromuscular control. During locomotion, ‘springy-limbs’ enable a number of elastic 
mechanisms that are exploited to improve performance. For example, properly timed stretch 
and recoil of series elastic tissues can be used to enhance muscle power output during 
acceleration, attenuate muscle power requirements during deceleration, or conserve 
mechanical and metabolic energy during steady speed locomotion [7].
The range of performance benefits afforded by compliant limbs in humans and animals has 
inspired wearable exoskeletons that may have applications in both gait rehabilitation and 
augmentation. Recently, a number of lower-limb exoskeletons have been developed that use 
elastic elements (i.e., springs and clutches) in parallel with the limb to strategically store and 
return energy and help power locomotion [8–15]. Physiological measurements in studies of 
vertical hopping in elastic exoskeletons spanning the whole limb [9] the knee joint [14] and 
the ankle joint [10, 12, 20] indicate performance benefits that include reduced muscle 
activity, reduced biological limb/joint stiffness and mechanical power output, and reduced 
metabolic energy cost of the user. These studies of simple movements like vertical hopping 
have paved the way for the continued development and implementation of elastic 
exoskeletons to improve user performance during human walking and running gaits.
During human walking, the majority of mechanical power comes from the ankle 
plantarflexors [21]. Furthermore, approximately half of the requisite mechanical power 
output at the ankle comes from elastic recoil of the Achilles’ tendon at ‘push-off’ [22]. 
Given the plantarflexors’ primary role in forward propulsion [23] and the significant elastic 
mechanism afforded by their compliant muscle-tendon architecture, the ankle joint seems to 
be a logical site for a passive elastic exoskeleton that can improve human walking 
performance.
We have recently developed a novel, passive elastic ankle exoskeleton that can store and 
return energy during the stance phase while allowing free ankle rotation during the swing 
phase of walking [8, 24, 25]. The key feature in the design is a rotary clutch that uses a 
ratchet and pawl configuration and two timing pins set to engage and disengage the 
exoskeleton spring at set ankle joint angles. The exoskeleton spring is engaged when the first 
timing pin pushes the pawl onto the ratchet at terminal swing, where the ankle dorsiflexes 
just prior to heel strike. This enables the spring to store and return elastic energy during 
stance. Then, once the ankle reaches extreme plantarflexion, after the foot is off the ground, 
a second timing pin pushes the pawl off of the ratchet, allowing the user to freely rotate their 
foot without interference from the exoskeleton spring. This exoskeleton design is simple, 
lightweight (<500 g), and requires no electronics or battery, making it a low cost option for 
gait assistance. We have recently shown that users can use this unpowered exoskeleton to 
reduce their metabolic cost of walking by ~7% below normal walking, but only when the 
exoskeleton spring (i.e., ‘exo-tendon’) is not too compliant and not too stiff [25]. The 
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reasons behind the existence of a ‘sweet-spot’ for ankle exoskeleton stiffness remain 
unresolved, principally because it is difficult to experimentally observe muscle-level effects 
of exoskeleton mechanical assistance.
The goal of this study was to develop and employ a simple in silico modeling tool to aid in 
the muscle-level understanding of the effects of increasing elastic ankle exoskeleton stiffness 
on underlying plantarflexor muscle-tendon mechanics and energetics during walking. 
Humans tend to reduce their biological ankle moment contribution in order to maintain 
consistent overall ankle joint kinetics during walking with ankle exoskeletons [11, 25, 29, 
30]. In line with this adaptive behavior, it follows that higher exoskeleton stiffness should 
result in increased unloading of biological muscle-tendons and larger reductions in the 
metabolic cost of plantarflexion during walking. On the other hand, if elastic ankle 
exoskeletons get too stiff, costly compensations might arise elsewhere in the lower-limb [31] 
or locally at the ankle in antagonistic muscle groups (e.g., tibialis anterior) to maintain 
steady gait mechanics. Furthermore, at the muscle-tendon level, increasing ankle 
exoskeleton stiffness could disrupt the normal ‘catapult mechanism’ exhibited by the ankle 
plantarflexors. That is, as parallel spring stiffness increases and the exoskeleton takes over 
more and more of the plantarflexor moment, the Achilles’ tendon should undergo less 
stretch requiring larger excursions of the muscles fascicles in series. Higher muscle 
shortening velocities are more metabolically costly. Thus, despite lower muscle force/
moment requirements, it is possible that unfavorable shifts in force–length or force-velocity 
operating point (e.g., higher shorting velocities) could increase metabolic energy 
requirements in the plantarflexor muscles and offset the potential benefit of increased 
assistance from elastic ankle exoskeletons [20, 32, 33].
To begin to resolve the reasons behind the ‘sweet-spot’ in ankle exoskeleton stiffness, we 
built a strategically simple musculoskeletal model of a passive elastic ankle exoskeleton 
working in parallel with the human ankle plantarflexors (Figure 1A.). We first used 
experimental kinematic and kinetic data from normal walking without exoskeletons at 1.25 
m/s, to identify the best set of morphological parameters and neural activation (M⃗bio) that 
generated ‘human-like’ ankle neuromechanics and energetics (e.g., [18]). Then with Mb⃗io as 
baseline, and an inverse framework (Figure 1B) we performed computer simulations to 
estimate how changes in ankle exoskeleton stiffness in parallel with the plantarflexors would 
impact the underlying biological muscle-level neuromechanics and energetics.
II. Methods
A. Model Composition
We constructed a simplified model of the human triceps surae using a single, lumped, 
uniarticular ankle plantarflexor (PF) muscle-tendon unit (MTU). Within the MTU there was 
a Hill-type contractile element (CE), representing the muscle fascicles, and a series elastic 
element (SEE), representing tendonous tisses (i.e., Achilles’ tendon and aponeuroses) [34] 
(Figure 1A). The extended model also included a spring in parallel with and operating 
through the same moment arm as the biological MTU (Figure 1A) in order to capture the 
dynamics of an elastic ankle exoskeleton (EXO). More details describing mathematical 
Sawicki and Khan Page 3
IEEE Trans Biomed Eng. Author manuscript; available in PMC 2017 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
relations used to model components of the MTU are provided in the online Supplementary 
Materials.
B. Setting Model Parameter Values
We set model parameters describing attachment geometry, MTU morphology and muscle 
(CE) and tendon (SEE) force production based on the latest anatomical and physiological 
data from the literature (e.g., [3, 16]) as well as computer optimization (e.g., [18]) to match 
model outputs to baseline experimental walking data (Table 1, un-bold and bold 
respectively). We termed this ‘baseline’ lumped muscle model without an exoskeleton the 
M⃗bio parameter configuration. More details on how we set parameters are provided in the 
online Supplementary Materials.
C. Extending the Model to Include an Elastic Ankle Exoskeleton
We modified the ‘baseline’ lumped muscle model configured to M ⃗bio (Table 1, bold; see 
Supp. Materials for more details) to include a passive elastic exoskeleton (EXO), 
represented by an additional passive elastic element operating in parallel with and along the 
same line of action as the lumped plantarflexor MTU (Figure 1A). In this configuration, the 
exoskeleton spring (i.e., exo-tendon) operated through the same moment arm (~4.1 cm) as 
the plantarflexor MTU throughout the stride- a simplification that is convenient for tying the 
exoskeleton back to parameters of the biological MTU (i.e., KSEE) and allows simple 
conversion to equivalent effective rotational stiffness values– both features that facilitate 
broad generalization to devices with varying geometries.
We modeled the mechanical action of EXO based on the passive ankle exoskeleton 
developed by Wiggin and colleagues which utilizes a clutch to strategically engage and 
disengage a coil tension spring according to kinematic cues based on ankle angle [8, 24, 25]. 
The length of the EXO spring always exactly tracked the length of the lumped plantarflexor 
MTU, LPFmtu (Equation 1).
(1)
To model the function of the clutch, the effective slack length of the EXO spring, LEXO0, 
was set to the MTU length at which the ankle angle transitioned from plantarflexion into 
dorsiflexion shortly after heel strike (Equation 2).
(2)
After this point, the EXO spring stored and released energy until the second transition from 
plantarflexion to dorsiflexion, at which time EXO force generation capability was 
terminated (i.e., shortly before swing). EXO force generation was modeled using a hookean 
spring with linear stiffness, KEXO (Equation 3).
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(3)
D. An Inverse Approach to Simulate Walking with Ankle Exoskeletons Over a Range of 
Stiffnesses
With the EXO component of the model defined and parameters of the lumped biological 
MTU set to M⃗bio we sought to examine changes in mechanics and energetics of the 
biological MTU during walking with exoskeleton springs ranging 0% to 100% of the MTU 
series elastic stiffness, KSEE = 315.4 N/mm. This yielded equivalent exoskeleton rotational 
stiffness values ranging from 0 N-m/rad (0 N-m/deg) up to 526.7 N-m/rad (9.19 N-m/deg), a 
value similar to that observed for the ankle joint in late stance during normal walking at 1.25 
m/s [35].
For these simulations we used an inverse approach (Figure 1B) that conserved ankle joint 
angle, θANGLE, and by extension the lumped plantar flexor muscle-tendon unit length 
change LPFmtu (i.e., kinematics) as well as the total plantarflexor moment profile mPFtotal 
(i.e., kinetics), generated by the M⃗bio solution. First, FEXO was calculated for each point in 
the stride according to Equation 3 and then converted to mEXO, assuming for simplicity that 
it followed the same line of action as the plantarflexors by applying a moment arm 
computed from the model’s skeletal geometry (~4.1 cm on average). Next we computed the 
moment generated by the biological MTUs, mPFmtu (plantarflexors) and mDFmtu 
(dorsiflexors) using Equation 4.
(4)
In cases where mEXO was greater than mPFtotal (i.e., mPFmtu < 0) we set mPFmtu= 0 and 
assumed that the excess exoskeleton moment (mEXO − mPFtotal) would be compensated for 
by a moment from the antagonist muscle compartment (i.e., dorsiflexors), mDFmtu to 
conserve the net ankle joint moment (see also Section E3 on Compensatory metabolic cost.)
Next, to get at the biological muscle-tendon dynamics we converted mPFtotal to FPFtotal, 
again using a moment arm computed from the model’s skeletal geometry (~4.1 cm on 
average). Given that all elements of the plantarflexor (PF) MTU are in series
(5)
we could use FSEE(t) (Equation 5) and KSEE to compute LSEE(t) (Equations S7, S8). LSEE(t) 
was then subtracted from LPFmtu(t) to determine the LCE(t) profile (Equation S9). With 
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LCE(t) defined for all points during the stride, we could compute a time derivative to obtain 
the muscle fascicle (CE) velocity, VCE(t). Finally, we could use our model for CE force to 
back calculate the muscle activation α(t) over the stride given the known FCE(t), LCE(t) and 
VCE(t) (Equation S1). At this point the forces, lengths and velocities of the EXO, MTU, SEE 
and CE, as well as the activation of the CE were all known and available to assess the 
muscle-level mechanical and energetic performance of a given exoskeleton stiffness during 
assisted walking.
E. Assessment Metrics for Quantifying Exoskeleton Performance at the Muscle Level
To evaluate the effects of different exoskeleton springs on underlying plantarflexor 
mechanics and energetics we calculated mechanical power of the MTU and its elements (CE 
and SEE) as well as the metabolic power of the CE.
E.1. Mechanical power—For a given element (MTU, CE or SEE), mechanical power (in 
watts), PMech(t), was calculated by taking the product of force and velocity at each time 
point over the stride (Equation 6).
(6)
The total positive mechanical work (in joules) performed by each element over the stride 
was also calculated by integrating the mechanical power curves over the stride only in 
regions with PMech > 0 (Equation 7).
(7)
E.2. Metabolic power—A mathematical model based on isolated muscle experiments was 
used to estimate the metabolic energy expenditure by the lumped plantarflexor muscles (CE) 
over the stride [36, 37] (Equations 8–11). The heat generated in each state of the muscle 
contraction, including maintenance, shortening, resting, and activation, are represented in 
this calculation. The metabolic power (in watts), PMet(t) is given as:
(8)
Where  represents empirically based heat measures that have been related to 
muscle velocity [36] (Equations 9, 10).
(9)
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(10)
Total metabolic work (in joules) expended over a stride was calculated by integrating the 
metabolic power curves (Equation 11).
(11)
E.3. Compensatory metabolic cost—A compensatory metabolic cost was also 
calculated for KEXO values in which exoskeleton forces/moments exceeded total 
plantarflexor forces/moments and resulted in a compensatory moment from the antagonist 
muscle compartment (i.e., dorsiflexors), mDFmtu per Equation 4. First we calculated the 
stride average metabolic cost per unit moment, C (in J/N-m) for the plantarflexors in the 
M⃗bio solution (i.e., the case with no exoskeleton included) (Equation 12).
(12)
Then, to compute the compensatory metabolic cost (in joules) we integrated and scaled the 
compensatory dorsiflexor moment mDF using the constant C (Equation 13).
(13)
III. Results
Exoskeletons with increasing stiffness developed higher and higher forces/moments over the 
period from ~10% to 60% of the walking stride (Figure 2, top). Because the total 
exoskeleton + biological plantarflexor moment was fixed in all conditions (i.e., invariant net 
ankle joint moment constraint), as the exoskeleton contribution to the total moment 
increased, the moment generated by lumped plantar flexor muscle forces (CE) 
systematically decreased (Figure 2, bottom; Figure 3). For the highest exoskeleton 
stiffnesses (e.g., 0.9 KSEE), the exoskeleton moment greatly exceeded the lumped 
plantarflexor moment necessary to maintain an invariant net ankle moment, especially early 
in the stride cycle. In these cases, a compensatory moment from antagonist muscles (e.g., 
dorsiflexors) was needed to maintain the net ankle force/moment from walking without an 
exoskeleton (Figure 2, bottom). In addition, for stiffnesses above ~0.5 KSEE (263 N-m/rad) 
the lumped plantarflexor muscle (CE) produced some passive force/moment (Figure 2, 
bottom; Figure 3).
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Lumped plantarflexor muscle fascicles (CE) underwent larger excursions during stance 
phase (~10–60% stride) with increasing exoskeleton spring stiffness (Figure 4). Because the 
ankle joint angle profile was conserved across all conditions, increasing exoskeleton forces 
served to reduce the force and strain in the SEE which, in turn, resulted in increased CE 
length changes (and CE velocities) with increasing exoskeleton stiffness. In fact, LCE 
surpassed LCE0 (strain > 1.0) for KEXO > ~0.5 KSEE, and resulted in passive force 
generation. CE strain values reached ~1.15 for the stiffest exoskeleton springs.
As exoskeleton spring stiffness (KEXO) increased, mechanical power/work generated by 
lumped plantarflexor muscle-tendon unit (MTU) decreased linearly due to systematic 
decreases in biological forces/moments (Figure 5, top; Figure 6). As expected, the power/
work performed by the CE was approximately equal in magnitude to the power/work 
performed by the SEE for the condition without an exoskeleton. As KEXO increased, the 
mechanical power/work generated by the muscle fascicles (CE) and series elastic tissues 
(SEE) both decreased, but the SEE well outpaced the CE leaving the CE as the dominant 
contributor to overall MTU power/work for exoskeletons with KEXO > ~0.1 KSEE (Figure 6). 
In fact, CE power/work did not decrease for KEXO < ~0.2 KEXO (~105 N-m/rad), as reduced 
CE forces traded-off with increased CE velocities/excursions (Figure 4) keeping CE power/
work relatively constant. For KEXO > 0.2 reductions in force began to dominate increases in 
velocity and CE power/work begin to sharply decline (Figure 6).
Lumped plantarflexor muscle (CE) activation and metabolic power/work both decreased 
with increasing exoskeleton stiffness (KEXO) (Figure 7). Metabolic cost decreased more 
slowly than muscle activation with increasing exoskeleton stiffness (Figure 7, bottom-left) 
because the higher CE velocities associated with stiffer exoskeleton springs required more 
activation to achieve similar force levels. That is, with higher exoskeleton spring stiffness, 
CE force/unit activation decreases due to unfavorable force-velocity effects. Although 
increasing KEXO sharply reduced the metabolic cost of the lumped plantarflexors, the 
metabolic cost of compensatory forces/moments needed to maintain an invariant net ankle 
moment sharply increased with increasing KEXO (Figure 7, bottom-right). As a result, the 
total metabolic cost had a minimum at KEXO = ~0.7 KEXO (~369 N-m/rad) and was ~30% 
lower than the cost of ankle muscle activity for normal walking without exoskeletons.
IV. Discussion
The goal of this study was to employ a strategically simple musculoskeletal model of an 
elastic ankle exoskeleton working in parallel with the biological plantarflexors to determine 
how exoskeleton stiffness would influence the neuromechanics and energetics of the 
underlying muscle-tendon units during walking. We hypothesized that increasing 
exoskeleton stiffness would result in (1) increased unloading of biological muscle-tendons 
and larger reductions in the metabolic cost of the plantarflexors during walking. 
Furthermore, we surmised that if exoskeletons got too stiff, (2) costly compensations might 
arise in other muscles in order to maintain steady gait mechanics. Finally, at the muscle-
tendon level, we hypothesized that (3) despite lower biological force/moment requirements 
due to exoskeleton assistance, it was possible that unfavorable changes in muscle operating 
length and/or higher muscle shortening velocities due to a disrupted ‘catapult mechanism’ 
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early in the stance phase of the stride could increase metabolic energy requirements in the 
plantarflexor muscles and offset some of the potential benefit of increased assistance from 
elastic ankle exoskeletons. Our modeling results support all of these hypotheses and suggest 
potential muscle-level mechanisms behind the recently observed ‘sweet spot’ in elastic ankle 
exoskeleton stiffness [25] that must now be confirmed with follow-up experiments using 
ultrasound imaging.
As expected, stiffer ankle exoskeleton springs resulted in larger decreases in plantarflexor 
metabolic energy consumption. Humans seem to employ a motor control strategy in order to 
maintain relatively invariant net ankle joint moments during locomotion with mechanical 
assistance from ankle exoskeletal devices [10–12, 15, 20, 25, 29, 30]. To capture the 
phenomenon of kinetic invariance in humans, we employed a modeling framework that 
enforced both the ankle angle and plantarflexor contribution to net ankle joint moment using 
experimental data from normal walking at 1.25 m/s. Not surprisingly, solutions with kinetic 
invariance demonstrated that increasing KEXO yields a clear trade-off between exoskeleton 
and biological muscle forces, with a ~50/50% sharing at KEXO = ~0.3 KSEE (~158 N-m/rad 
= 2.8 N-m/deg) (Figure 3). In addition, solutions with higher KEXO required muscle 
activation with lesser magnitude and later onset (Figure 7, top left), a result consistent with 
recent experimental data showing decreases in soleus activity that are more pronounced with 
higher exoskeleton springs stiffness [25]. We note, without this timing shift, the lumped 
plantarflexor muscles (CE) would have produced unnecessary forces/moments between 
~10% and 60% of the stride when exoskeleton assistance mEXO was already sufficient 
(Figure 2). Thus, in line with our hypothesis (1), as the biological force/moment requirement 
declined with increasing KEXO, so did muscle activation, which was the main driver of 
metabolic cost (Figure 7),
Metabolic cost of the plantarflexors reached a minimum value of ~11% of the value during 
unassisted walking (50.3 J *0.11 = 5.5 J per leg) with a KEXO of ~0.8 KSEE (~421N-m/rad = 
7.4 N-m/deg) (Figure 7, bottom-right). But, is more necessarily better when it comes to 
ankle exoskeleton stiffness selection [25, 33, 38] ? Interestingly, in our model, assisting with 
a KEXO ≥ ~0.5 KSEE (263 N-m/rad) began to induce passive stretch in the muscle fascicles 
(CE) and thus a passive muscle moment contribution. While relying more on passive 
contributions to muscle force could have metabolic benefit, it also elicits an unavoidable 
deviation in the ankle force/moment profile from normal walking (Figure 2, 3). Thus, due to 
shifts in the operating point of underlying muscles to longer lengths (Figure 4), perfectly 
conserving the mPFtotal may become increasingly difficult, and could be a factor that limits 
performance for exoskeletons employing high parallel stiffness [11, 25, 31].
If humans choose to move with very strict ankle moment invariance, our model suggests that 
they may reject exoskeletons with stiffness ≥ 0.5 KSEE (or ~50–60% of normal ankle joint 
rotational stiffness during walking at 1.25 m/s [35]), where passive forces in plantarflexors 
are unavoidable. This could severely limit the potential for metabolic savings to only ~60% 
of the total plantarflexor contribution or ~15% overall [39]. Solutions with KEXO ≥ 0.5 KSEE 
(263 N-m/rad) begin to significantly produce excess exoskeleton forces/moments early in 
the stance phase (Figure 2). To maintain net ankle moment invariance, these excess moments 
would need to be countered by significant antagonist moments coming from ankle 
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dorsiflexors or adjustments in posture, both of which would likely incur a compensatory 
metabolic cost (Figure 7, lower-right). Thus, a 15% reduction in overall metabolic cost of 
walking seems a high end estimate.
Interestingly, when adding in our estimate for the metabolic cost of compensatory force/
moment of ankle antagonists (i.e., dorsiflexors), our model predicts a broad ‘sweet-spot’ 
between KEXO = 0.6 and 0.8 KSEE (~316–420 N-m/rad) with a net metabolic benefit of 
~30% for the ankle plantarflexors. Using Umberger’s estimate that plantarflexors account 
for ~27% of the total metabolic cost of walking [39, 40], this is equivalent to an overall 
reduction in the metabolic cost of walking of ~8% and falls very near the measured value in 
Collins et al. [25], albeit at a higher range of exoskeleton stiffness. Collins et al. found the 
‘sweet-spot’ at 180 N-m/rad, about half the stiffness for the metabolic minimum reported 
here. The mismatch is likely due to the very rudimentary approach we took to the 
compensatory metabolic cost in this study, which assumed dorsiflexors and plantarflexors 
have the same metabolic cost per unit moment (C in Equation 13) and did not account for 
the metabolic cost of compensation elsewhere in the body (e.g., increased knee flexor 
moments).
Despite the mismatch in the ‘sweet spot’ stiffness between our model and experiments, our 
results still lend some support to hypothesis (2) that metabolically costly compensation may 
be at play to maintain invariant net ankle moment in the face of increasing exoskeleton 
spring stiffness, an idea that is also corroborated by data from Collins et al. [25] indicating 
both local and global neuromechanical compensations during walking with parallel springs. 
At the ankle compensation appears as elevated tibialis anterior muscle activity in early 
stance and late swing. More globally, increased knee joint moments appear near the stance-
swing transition--an effect not captured by the current model.
Despite the potential for significant metabolic savings due to reduced muscle forces and 
activations (Figure 2, 3, 7), our results also support hypothesis (3), that elastic ankle 
exoskeletons could significantly disrupt the normal ‘catapult action’ of the plantarflexors 
during human walking. Our model of normal walking at 1.25 m/s (i.e., KEXO = 0) captures 
the normal muscle-tendon interaction dynamics of the plantarflexors and Achilles’ tendon 
during walking with nearly isometric muscle fascicles during stance phase (Figure 4, bold 
red) and large amounts of elastic energy storage and return in series elastic tissues (Figure 5, 
middle, bold blue) [22, 41]. This results in a large burst of mechanical power at push-off that 
is shared ~50/50 between muscle fascicles (CE) and series elastic tissues (SEE) (Figure 5, 6) 
[22]. However, as KEXO increases, unloading of the biological MTU causes less and less 
stretch in the SEE and more and more stretch in the CE, disrupting the normal ‘catapult-like’ 
muscle-tendon interaction (Figure 4, 5, 6).
The observation of larger CE excursions with parallel mechanical assistance is consistent 
with recent muscle-level experiments during spring-loaded human hopping. Soleus fascicles 
undergo increased excursions in the presence of a parallel spring (KEXO = 91 N-m/rad) 
providing assistive plantarflexor torque [20]. In that case, reduced forces were counteracted 
by increased length changes resulting in no difference in soleus muscle fascicle work 
between spring-loaded and unassisted hopping conditions. Our model of spring-loaded 
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walking makes a similar prediction that CE work does not decrease for values of KEXO up to 
~0.2 KSEE (~ 105 N-m/rad = 1.8 N-m/deg) (Figure 6). For exoskeleton stiffness values > 0.2 
KSEE, CE work begins to decline as reductions in muscle force outpace increases in CE 
length changes. Perhaps more striking is the rapid reduction in the mechanical work 
performed by SEE recoil with increasing exoskeleton spring stiffness. Without assistance 
from the exoskeleton, the SEE recoil contributes an equal amount of mechanical power as 
CE shortening, but the SEE contribution is reduced to nearly zero for KEXO ≥ 0.7 KSEE 
(~369 N-m/rad), completely eliminating the ability of the biological MTU to function as a 
catapult (Figure 6).
Increasing reliance on the CE for MTU power production limits the metabolic benefit of 
increasing exoskeleton spring stiffness. The lack of mechanical power from elastic recoil of 
the SEE is mostly supplanted by elastic recoil of the exoskeleton spring, but not without 
some consequence. Our metabolic cost model is driven by muscle activation, force-length 
and force-velocity dynamics [36] (Equations 8–11). As exoskeleton spring stiffness 
increases, the required muscle activation declines because biological muscle force 
requirements are reduced. We note, however, that reductions in metabolic cost occur at a 
slower rate than reductions in muscle activation (Figure 7, bottom-left). This is a direct side 
effect of the metabolic penalty associated with higher CE shortening velocities due to the 
increased muscle excursions characteristic of a disrupted ‘catapult action’ (Figure 4). 
Interestingly, because muscle fascicles nominally operate down the ascending limb (Figure 
4, red bold curve), exoskeleton assistance tends to increase average fascicle lengths toward 
LCEo, an operating point that is more favorable for force production- an effect that is 
trumped by far less favorable force-velocity operating points. Thus, in general, it would 
seem that exoskeletons designed to assist MTUs with compliant architecture may be 
inherently limited in their metabolic benefit. One way out of this conundrum might be for 
the user to adjust their joint kinematics (and therefore MTU length change pattern) in order 
to attenuate increases in underlying fascicle velocity that counteract the metabolic reductions 
due to reduced muscle forces and activations [20]. Indeed, altered joint kinematics indicative 
of shorter MTU lengths (i.e., exaggerated plantarflexion) have been observed during walking 
with powered ankle orthoses [2, 29, 30] - a strategy that may limit metabolic penalty due to 
a disrupted ‘catapult mechanism’.
Aside from improving metabolic performance of the user, exaggerated plantar flexion during 
walking with an ankle exoskeleton could be indicative of an injury avoidance mechanism. 
Although non-intuitive, walking with relatively stiff exoskeleton springs could induce 
passive stretch at high rates in the CE and increase the likelihood of a muscle strain injury 
[42]. In our simulations, the CE strain reached maximum values of ~115% for the stiffest 
exoskeleton spring (Figure 4), but for tasks where the MTU operates at longer lengths and/or 
faster velocities (e.g., faster walking or walking uphill), it is possible that strains/strain rates 
might reach dangerous levels with relatively stiff exoskeletons (e.g. KEXO > 0.9% KSEE = 
475 N-m/rad).
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Model limitations
We made a number of simplifications and assumptions in developing the model and 
simulations used in this study that are worth addressing. First and foremost, we greatly 
simplified the attachment geometry, muscle-tendon architecture, and mechanisms driving 
force production in our musculoskeletal model of the triceps surae (i.e., medial 
gastrocnemius (MG), lateral gastrocnemius (LG) and soleus (SOL)). Briefly, we combined 
the triceps surae group into a single, ‘lumped’ uniarticular muscle-tendon with a soleus like 
origin and insertion locations, but with a force generating capacity of the summed MG + LG 
+ SOL. Despite its simplicity, we believe the model captures the salient features and 
behaviors exhibited by the human plantar flexors during walking that are relevant to the 
questions we address in this study.
The inverse modeling framework we employed assumed that the overall ankle joint 
kinematics and kinetics during walking at 1.25 m/s remain invariant in the context of elastic 
ankle exoskeletons. While there is strong evidence that humans do indeed exhibit invariance 
in ankle joint moments during walking [11, 25, 29, 30], the evidence for ankle joint angle 
invariance is weaker. For example, Kao et al. demonstrated that, while ankle kinetics are 
conserved when some plantar flexor moment is provided by a robotic exoskeleton, ankle 
kinematics tend to shift to more plantarflexed postures [29]. This finding has been 
corroborated by others who use ankle exoskeletons during human walking studies [2, 30]. 
We note that it is entirely possible that the devices used in previous studies were not properly 
‘tuned’ to reproduce both ankle kinetics and kinematics during the studied gait pattern. In 
fact, our study strongly suggests that assistive devices that are not properly ‘tuned’ could 
lead to deviations from normal moments (Figure 3) unless the user significantly adjusts their 
joint kinematics and/or muscle activation patterns (Figure 7).
On the other hand, it may be that the conditions we simulated, maintaining kinematic and 
kinetic invariance, are not the best strategy for minimizing metabolic cost. A gait pattern 
with more plantarflexed posture or a higher total net plantarflexor moment may be able to 
better optimize the tradeoff between the energy savings from reduced plantarflexor forces/
muscle activations and the additional energy costs of altered movement at other places in the 
body (e.g., knee or hip).
To address these open questions, our future work will aim toward a more complete model 
with more detailed anatomy and physiology that incorporates all of the individual ankle joint 
muscle-tendons and the rest of the lower-limb as along with an elastic ankle exoskeleton 
(e.g., [32] for hopping) during human waking. We will use our inverse framework, but drive 
the simulations with actual kinematic and kinetic data from walking with elastic 
exoskeletons with varying spring stiffness (e.g., [25]) rather than imposing invariant 
constraints as we did in the current study. Comparing and contrasting the fully constrained 
model presented here, with a model driven by ‘real-world’ exoskeleton walking data will 
provide important insights into the muscle-level mechanisms that may be guiding human 
preference during locomotion with exoskeleton assistance. We also plan to use ultrasound 
imaging to verify model predictions of underlying fascicle behavior during exoskeleton 
assisted walking. Indeed, a grand challenge in the field of wearable robotics is to develop a 
modeling and simulation framework that does not rely at all on imposed kinematic or kinetic 
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constraints (from data or otherwise) to predict how walking mechanics and energetics would 
change in the context of novel devices.
Insights into improving current ankle exoskeleton designs
In this study, we have highlighted a number of limitations inherent in passive elastic 
exoskeleton designs [8, 24] that may be overcome with improvements in future designs. The 
primary drawback to the device we simulated was that it produced forces too early in the 
stance phase that often exceeded those needed to produce a normal ankle joint moment. This 
effect was particularly noticeable as the exoskeleton spring stiffness increased (Figure 2, 3). 
With the current design, avoiding this excess exoskeleton moment would require either (a) a 
change in ankle joint kinematics; or (b) co-activation by ankle dorsiflexors to adjust the net 
ankle moment downward; or (c) walking with excessive total ankle joint moments - all of 
which could be considered undesirable effects. Changes in the exoskeleton design could also 
improve performance. For example, a passive device with non-linear spring stiffness (i.e., a 
stiffening spring), and/or a changing moment arm could be designed with a custom torque 
angle curve appropriate for a given gait. In addition, timing engagement of the spring with a 
more versatile clutching mechanism could provide flexibility in when the exoskeleton torque 
onset occurs during a gait cycle. Of course, a device with motors could achieve all of the 
aforementioned performance features by employing customized gait-phase dependent torque 
control that is optimized to maximize metabolic benefit while maintaining joint kinetics and 
kinematics.
V. Conclusion
Our modeling results and recent experimental evidence [25] both indicate that, for devices 
intended to reduce metabolic cost of human locomotion by assisting compliant joints (e.g., 
ankle), the name of the game is to reduce muscle forces and activations. This idea represents 
somewhat of a paradigm shift from previous solutions focusing on reducing biological 
muscle-tendon/joint positive mechanical power outputs [30, 43, 44], especially in late stance 
phase. Passive elastic solutions are a promising alternative as they are well-suited for 
reducing muscle force and activation requirements in parallel biological muscle-tendon units 
even during periods of energy absorption [25].
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
(A) Modeling schematic. We modeled the combined triceps surae (soleus and gastrocnemius 
muscles) as a single lumped uniarticular plantarflexor (PFmtu) attached along the shank 
Lshank to the calcaneus with length LPFmtu and moment arm LPF–MA (left). The lumped 
PFmtu generated force according to a Hill-type muscle-tendon model with a muscle 
contractile element (CE) comprising active (F(t), red) and passive (blue parallel spring) 
components and a series elastic component (SEE) representing the Achilles’ tendon and 
aponeurosis. We modeled a passive elastic ankle exoskeleton (EXO) as a spring in parallel 
with the PFMTU and acting through the same moment arm LPF–MA (right). (B) Block 
diagram of computational flow in the inverse modeling framework used to simulate changes 
in muscle-level dynamics during walking with exoskeletons of varying spring stiffness, 
KEXO. First, using the defined skeletal geometry, the plantar flexor moment, mPFmtu and 
ankle joint angle, θANGLE from normal walking at 1.25 m/s were converted to a plantar 
flexor force, FPFmtu and plantar flexor length, LPFmtu, respectively. Then, we used the series 
elastic element stiffness, KSEE to compute SEE length, LSEE; and the exoskeleton stiffness, 
KEXO to compute exoskeleton force, FEXO. Next, we could use subtraction to define the 
force (FCE), length (LCE), and velocity (VCE), of the muscle. Finally, these values were used 
along with models of muscle force production and metabolic energy use to compute muscle 
activation (Act), mechanical power output (Pmech) and metabolic power output (Pmet).
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Fig. 2. 
The total contribution to ankle joint moment from the lumped plantarflexors and the elastic 
ankle exoskeleton (biological +exoskeleton) (Top, black) and the moment generated by the 
exoskeleton (exoskeleton only) (Top, gray) over a walking stride from heel strike (0%) to 
heel strike (100%) for different exoskeleton spring stiffnesses. The total moment is always 
the same because we constrained the model to follow the plantarflexor contribution to net 
ankle moment during unassisted walking (i.e., M⃗bio solution) in all conditions. The active 
(Bottom, red) and passive (Bottom, purple) lumped plantarflexor muscle (CE) moment (i.e., 
biological only) for different exoskeleton spring stiffnesses. For exoskeleton springs >0.2 
KSEE the exoskeleton moment exceeds the total moment and necessitates a compensatory 
antagonist moment from dorsiflexors (Bottom, shaded area=difference between orange 
curves and solid red curve) to maintain an invariant net ankle moment. Curves are plotted for 
exoskeleton stiffness values ranging from 0.2 KSEE (~105 N-m/rad) to 0.9 KSEE (~474 N-m/
rad).
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Fig. 3. 
Peak force versus exoskeleton spring stiffness for the total = exoskeleton + lumped 
plantarflexors (solid black), exoskeleton only (dashed black), and the active (solid red) and 
passive (solid purple) elements of the lumped plantarflexor muscles (CE). For each 
exoskeleton stiffness all forces are normalized to the peak total force (~3200 N) without an 
exoskeleton. Exoskeleton spring stiffness of 100% KSEE is equivalent to ~527 N-m/rad.
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Fig. 4. 
Lumped plantarflexor muscle fascicle (CE) strain over a walking stride from heel strike 
(0%) to heel strike (100%) for different exoskeleton spring stiffnesses. The solid red line is 
the fascicle strain pattern taken from Rubenson et al [1] for M⃗bio solution. Curves are plotted 
for exoskeleton stiffness values ranging from 0.2 KSEE (~105 N-m/rad) to 0.9 KSEE (~474 
N-m/rad).
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Fig. 5. 
Mechanical power over a walking stride from heel strike (0%) to heel strike (100%) for the 
lumped plantarflexor muscle-tendon unit (MTU) (Top, green); elastic tissues (SEE) (Middle, 
blue) and muscle fascicles (CE) (Bottom, red). Curves with varying line types represent 
different exoskeleton stiffness values ranging from no exoskeleton (bold) up 0.9 KSEE (~474 
N-m/rad).
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Fig. 6. 
Positive mechanical work versus exoskeleton spring stiffness for the lumped plantarflexor 
muscle fascicles (CE) (red), elastic tissues (SEE) (blue), and muscle-tendon unit (MTU) 
(green). Exoskeleton spring stiffness of 100% KSEE is equivalent to ~527 N-m/rad.
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Fig. 7. 
(Top) Lumped plantarflexor muscle fascicle (CE) activation (Top left) and metabolic power 
(Top right) over a walking stride from heel strike (0%) to heel strike (100%) for different 
exoskeleton spring stiffnesses. The solid red lines represent walking without an exoskeleton 
(i.e., the M⃗bio solution). Curves of varying line type represent exoskeleton stiffness values 
ranging from 0.2 KSEE (~105 N-m/rad) to 0.9 KSEE (~474 N-m/rad).
(Bottom) Integrated activation (Left, dashed) and metabolic power (i.e., work) (Left, solid) 
versus exoskeleton spring stiffness for the lumped plantarflexor muscle fascicles (CE). 
Integrated metabolic power (Right, red) is modified (Right, black) to include an estimated 
compensatory metabolic cost (Right, dashed gray) due to the antagonist dorsiflexor muscle 
moment required to maintain an invariant net ankle moment. All values are normalized to 
the no exoskeleton condition. Exoskeleton spring stiffness of 100% KSEE is equivalent to 
~527 N-m/rad.
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TABLE I
BASELINE MODEL PARAMETERS AND M⃗bio SOLUTION
Parameter Value (units) (Norm.) Source/Details
Body Mass 70 kg Average mass of subjects from experimental data set for walking at 1.25 m/s [2]. Within 
1 SD of average subject mass from Ward et al. (82.7 ± 15.2 kg) [3].
Body Height 1.70 m Average height of subjects from experimental data set for walking at 1.25 m/s [2]. 
Within 1 SD of average subject height from Ward et al. (168.4 ± 9.3 m) [3].
Shank Length, LSHANK 0.400 m Set 0.03 m greater than tibial length from Ward et al. (37.1 ± 2.2 cm) [3] to include 
distance to femoral condyles.
FCEMAX 6000 N Similar to approximations for soleus + med. and lat. gastrocnemius muscles used by 
Arnold et al. (5500.3 N) [16] and others [17–19].
VCEMAX 0.326 m/s (8.24 × LCE0) Based on values for soleus and combined gastrocnemius reported by Geyer et al. [19] 
and scaled using physiological cross section (PCSA) data from Ward et al. [3]
LCE0/LPFmtu0 0.108 (unitless) Based on fascicle lengths for soleus, med. gastrocnemius and lat. gastrocnemius reported in Ward et al. [3] and tendon slack lengths reported in Arnold et al. [16] and scaled using 
physiological cross section (PCSA) data from Ward et al. [3]
LPFmtu0 0.366 m (0.92 × LSHANK)
 LCE0 0.040 m (0.10 × LSHANK) These values (in bold) were all obtained using an optimization to find the morphology 
that would minimize error between the modeled and measured plantarflexor moment 
based on inverse dynamics analysis of human walking data collected at 1.25 m/s. See 
text for details
 LSEE0 0.326 m (0.82 × LSHANK)
 KSEE 315.4 N/mm The stiffness of the SEE that resulted in the best match of model and experimental 
plantarflexor moment is consistent with values reported for the Achilles’ tendon in the 
literature from both models (375.6 N/mm) [18] and experiments (188 N/mm–805 
N/mm) [26–28].
*
Parameters are all defined in more detail within the text. Bold indicates a parameter set using optimization to match model and experimental data 
((M⃗bio); un-bold indicates a parameter based on values taken from literature.
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